Diabetes Engagement and Activation Platform for Implementation and Effectiveness of Automated Virtual Type 2 Diabetes Self-Management Education: Randomized Controlled Trial
Open Access
- 29 March 2021
- journal article
- research article
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 6 (1) , e26621
Abstract
Background: Patients with type 2 diabetes require recommendations for self-management education and support. Objective: In this study, we aim to design the Diabetes Engagement and Activation Platform (DEAP)—an automated patient education tool integrated into primary care workflow—and examine its implementation and effectiveness. Methods: We invited patients aged 18-85 years with a hemoglobin A1c (HbA1c) level ≥8 to participate in a randomized controlled trial comparing DEAP with usual care. DEAP modules addressing type 2 diabetes self-management education and support domains were programmed into patient portals, each with self-guided educational readings, videos, and questions. Care teams received patient summaries and were alerted to patients with low confidence or requesting additional help. HbA1c, BMI, and systolic and diastolic blood pressure (DBP) were measured. Results: Out of the 680 patients invited to participate, 337 (49.5%) agreed and were randomized. All of the 189 intervention patients accessed the first module, and 140 patients (74.1%) accessed all 9 modules. Postmodule knowledge and confidence scores were high. Only 18 patients requested additional help from the care team. BMI was lower for intervention patients than controls at 3 months (31.7 kg/m2 vs 32.1 kg/m2; P=.04) and 6 months (32.5 kg/m2 vs 33.0 kg/m2; P=.003); improvements were even greater for intervention patients completing at least one module. There were no differences in 3- or 6-month HbA1c or blood pressure levels in the intent-to-treat analysis. However, intervention patients completing at least one module compared with controls had a better HbA1c level (7.6% vs 8.2%; P=.03) and DBP (72.3 mm Hg vs 75.9 mm Hg; P=.01) at 3 months. Conclusions: The findings of this study concluded that a significant proportion of patients will participate in an automated virtual diabetes self-management program embedded into patient portals and health systems show promise in helping patients manage their diabetes, weight, and blood pressure. Trial Registration: ClinicalTrials.gov NCT02957721; https://clinicaltrials.gov/ct2/show/NCT02957721Keywords
All Related Versions
This publication has 19 references indexed in Scilit:
- A Systematic Review of Electronic Portal Usage Among Patients with DiabetesDiabetes Technology & Therapeutics, 2014
- Changes in HbA1c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication ChangePLOS ONE, 2014
- A systematic review of IT for diabetes self-management: Are we there yet?International Journal of Medical Informatics, 2013
- Assessing the Value of the Diabetes EducatorThe Diabetes Educator, 2011
- Cluster-Randomized Trial of a Mobile Phone Personalized Behavioral Intervention for Blood Glucose ControlDiabetes Care, 2011
- Internet and information technology use in treatment of diabetesInternational Journal Of Clinical Practice, 2010
- Projecting the Future Diabetes Population Size and Related Costs for the U.S.Diabetes Care, 2009
- Access to Diabetes Self-management EducationThe Diabetes Educator, 2009
- An Electronic Linkage System for Health Behavior CounselingAmerican Journal of Preventive Medicine, 2008
- Effectiveness of Pharmacist‐Administered Diabetes Mellitus Education and Management ServicesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005